Phase 4 Psoriasis Clinical Trials
26 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–20 of 26 trials
Recruiting
Phase 4
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
PsoriasisOverweight or Obesity
Eli Lilly and Company200 enrolled43 locationsNCT06857942
Recruiting
Phase 4
Development of Predictive Psoriasis Response Endotypes Using Single Cell Transcriptomics
Psoriasis
University Hospitals Cleveland Medical Center56 enrolled1 locationNCT05270733
Recruiting
Phase 4
Multi-Center PAMPA Study
Psoriasis
NYU Langone Health176 enrolled5 locationsNCT05004727
Recruiting
Phase 4
Proactive TDM Versus Standard Use of Biologics in Psoriasis
Psoriasis Vulgaris
University Hospital, Ghent210 enrolled15 locationsNCT06398106
Recruiting
Phase 4
Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis
Psoriasis (PsO)
Hospital Universitario Dr. Jose E. Gonzalez62 enrolled1 locationNCT07401992
Recruiting
Phase 4
Bimekizumab in Plaque Psoriasis
Plaque Psoriasis
Icahn School of Medicine at Mount Sinai60 enrolled2 locationsNCT06336343
Recruiting
Phase 4
A Safety and Pharmacokinetics Study of IDP-118 Lotion in Pediatric Participants With Plaque Psoriasis
Psoriasis
Bausch Health Americas, Inc.45 enrolled9 locationsNCT03988439
Recruiting
Phase 4
A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis
Psoriasis
Bausch Health Americas, Inc.45 enrolled9 locationsNCT03987763
Recruiting
Phase 4
A Multi-center RCT Clinical Trial on Personalized Precision Medicine for Patients With Psoriasis and Psoriatic Arthritis and Investigation on Cardiovascular Biomarkers
PsoriasisPsoriasis ArthritisBiologics
Taichung Veterans General Hospital50 enrolled2 locationsNCT07149792
Recruiting
Phase 4
Potential Role of Guselkumab in Modulating PAIN Perception and Related Gene Pathways: a Proof-of-concept Study.
Psoriasis Arthritis
Fondazione Policlinico Universitario Campus Bio-Medico26 enrolled1 locationNCT06974474
Recruiting
Phase 4
Correction of Psoriatic T Cell Signatures by Deucravacitinib
Psoriasis Vulgaris
University of California, San Francisco25 enrolled1 locationNCT05858645
Completed
Phase 4
Pilot study of a branded (marketed) formulation betamethasone dipropionate called Diprosone® OV ointment applied to the skin in healthy male and female volunteers to determine the appropriate dose duration (ED50) for use in a pivotal in vivo bioequivalence study.
Diprosone OV ointment is indicated for the topical treatment of eczema and psoriasis in children and adults.
Zenith Technology Corporation Limited12 enrolled1 locationACTRN12623001181695
Completed
Phase 4
Pilot study of a branded (marketed) formulation betamethasone dipropionate called Diprosone® ointment applied to the skin in healthy male and female volunteers to determine the appropriate dose duration (ED50) for use in a pivotal in vivo bioequivalence study.
Diprosone ointment is indicated for the topical treatment of eczema and psoriasis in children and adults.
Zenith Technology Corporation Limited12 enrolled1 locationACTRN12623001179628
Recruiting
Phase 4
Immune Spatial Features of Guselkumab Cutaneous Response
Psoriasis of Scalp
University of California, San Francisco10 enrolled1 locationNCT05858632
Completed
Phase 4
Pilot study of a branded (marketed) formulation betamethasone dipropionate called Diprosone® cream applied to the skin in healthy male and female volunteers to determine the appropriate dose duration (ED50) for use in a pivotal in vivo bioequivalence study.
Diprosone cream is indicated for the topical treatment of eczema and psoriasis in children and adults.
Zenith Technology Corporation Limited12 enrolled1 locationACTRN12623000887673
Completed
Phase 4
Pilot study of a branded (marketed) formulation methylprednisolone aceponate called Advantan fatty ointment applied to the skin in healthy male and female volunteers to determine the appropriate dose duration (ED50) for use in a pivotal in vivo bioequivalence study.
Advantan fatty ointment is indicated for the topical treatment of eczema and psoriasis in children and adults.
Zenith Technology Corporation Limited12 enrolled1 locationACTRN12623000272695
Recruiting
Phase 4
Outcomes With Treatment and Withdraw of Ixekizumab in Patients With Plaque Psoriasis
Plaque Psoriasis
Singapore General Hospital40 enrolled1 locationNCT04537689
Completed
Phase 4
Pilot study of a branded (marketed) formulation methylprednisolone aceponate called Advantan ointment applied to the skin in healthy male and female volunteers to determine the appropriate dose duration (ED50) for use in a pivotal in vivo bioequivalence study.
Advantan ointment is indicated for the topical treatment of eczema and psoriasis in children and adults.
Zenith Technology Corporation Limited12 enrolled1 locationACTRN12622001295730
Not Yet Recruiting
Phase 4
CH-ALV-2001: A study assessing variations in how quickly STELARA is processed and cleared by the body, in healthy adult males.
Psoriasis
Christchurch Clinical Studies Trust22 enrolled1 locationACTRN12620000584932
Recruiting
Phase 4
Duobrii in Combination With Biologics
Psoriasis
Psoriasis Treatment Center of Central New Jersey25 enrolled1 locationNCT04119102